Plus, a firm with three hyperscale leases signed, a biotech with four drugs on market, and a stock down 29% that activists just shook up.
Mar 28, 2026
Aug 8, 2026
•
1 min read
Plus, a Street-high target on a lagging tech giant...
Aug 1, 2026
One stock pick from a top-ranked analyst with an implied upside of 100% or more.
Plus, Wall Street's highest target on a major data platform...